Prion Disease: An Overview of a Unique Neurodegenerative Disorder

Introduction

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of rare and fatal neurodegenerative disorders that affect both humans and animals. These diseases are caused by prions, which are misfolded proteins that can induce other normal proteins in the brain to also misfold, leading to brain damage and a range of neurological symptoms.

History and Discovery

Prion diseases have been known for centuries, particularly in the context of scrapie in sheep, which was first described in the 18th century. However, the modern understanding of prion diseases began in the 20th century with the study of Creutzfeldt-Jakob disease (CJD) and Kuru, a disease found among the Fore people of Papua New Guinea. The term “prion” was coined by Dr. Stanley B. Prusiner in 1982, who later received the Nobel Prize in Physiology or Medicine in 1997 for his research on prions.

Types of Prion Diseases

Prion diseases can be categorized into three main types: sporadic, genetic, and acquired.

1.Sporadic Prion Diseases

Sporadic prion diseases occur without any known cause and account for the majority of prion disease cases. The most common sporadic prion disease is sporadic Creutzfeldt-Jakob disease (sCJD), which typically affects individuals between the ages of 50 and 75.

2.Genetic Prion Diseases

Genetic prion diseases are caused by mutations in the PRNP gene, which encodes the prion protein. These mutations can be inherited in an autosomal dominant manner. Examples of genetic prion diseases include familial Creutzfeldt-Jakob disease (fCJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI).

3.Acquired Prion Diseases

Acquired prion diseases are transmitted through exposure to infectious prions from contaminated medical equipment, consumption of infected meat, or other means. Notable examples of acquired prion diseases include variant Creutzfeldt-Jakob disease (vCJD), which is linked to bovine spongiform encephalopathy (BSE) or “mad cow disease,” and Kuru.

Pathophysiology

Prions are abnormal, misfolded forms of a naturally occurring protein called the prion protein (PrP). The normal form of PrP is found on the surface of cells in the brain and other tissues. In prion diseases, the normal PrP undergoes a conformational change to become a pathogenic, misfolded form known as PrP^Sc. This misfolded protein is resistant to proteases, enzymes that normally break down proteins, and can induce other normal PrP molecules to misfold and aggregate, forming amyloid plaques and causing neuronal cell death.

Symptoms and Clinical Presentation

The symptoms of prion diseases vary depending on the specific type but generally include rapidly progressive dementia, motor dysfunction, and psychiatric symptoms. Early signs may include memory loss, behavioral changes, and coordination problems. As the disease progresses, affected individuals may experience severe cognitive decline, muscle stiffness, involuntary movements, and difficulty speaking and swallowing.

Specific Clinical Features

• Creutzfeldt-Jakob Disease (CJD): Rapidly progressive dementia, myoclonus (sudden muscle jerks), visual disturbances, and ataxia (loss of coordination).
• Gerstmann-Sträussler-Scheinker Syndrome (GSS): Progressive ataxia, dysarthria (slurred speech), and movement disorders.
• Fatal Familial Insomnia (FFI): Severe insomnia, autonomic dysfunction, and motor disturbances.
• Kuru: Tremors, ataxia, and emotional instability, followed by severe motor and cognitive decline.
• Variant Creutzfeldt-Jakob Disease (vCJD): Psychiatric symptoms such as depression and anxiety, followed by neurological signs like ataxia and dementia.

Diagnosis

Diagnosing prion diseases can be challenging due to their rarity and the overlap of symptoms with other neurodegenerative disorders. A combination of clinical evaluation, neuroimaging, and laboratory tests is typically used to make a diagnosis. Key diagnostic tools include:

• Magnetic Resonance Imaging (MRI): Can reveal characteristic brain changes, such as hyperintensities in specific regions.
• Electroencephalography (EEG): May show periodic sharp wave complexes, particularly in CJD.
• Cerebrospinal Fluid (CSF) Analysis: Tests such as 14-3-3 protein detection and real-time quaking-induced conversion (RT-QuIC) can support the diagnosis.
• Genetic Testing: Identifies mutations in the PRNP gene in cases of genetic prion diseases.
• Brain Biopsy or Autopsy: Definitive diagnosis can be made by detecting prion protein deposits and spongiform changes in brain tissue.

Treatment and Management

Currently, there is no cure for prion diseases, and treatment is primarily supportive and palliative. The focus is on managing symptoms and providing quality end-of-life care. Research is ongoing to develop potential therapies, including drugs that target prion replication and immunotherapy approaches.

Treatment emphasizes palliative care to manage symptoms so people are as comfortable as possible. For example, providers may prescribe:

• Antiseizure drugs or muscle relaxants for myoclonus (muscle twitch).
• Opioids for pain.

Prevention and Public Health Measures

Preventing prion diseases involves measures to minimize exposure to infectious prions. These include:

• Implementing strict guidelines for the handling and disposal of potentially contaminated medical equipment.
• Regulating the processing and consumption of animal products to prevent the spread of BSE.
• Conducting surveillance and monitoring to identify and control outbreaks of prion diseases.

Complications of prion disease

Prion disease complications come in a cascade of issues that not only affect the person with the disease, but also the family members and friends who care for that person.

Prion disease complications may develop within a few months to a year from when someone first had symptoms. Complications may include:

• Losing the ability to take care of oneself.
• Dementia.
• Mutism.
• Coma (final stage).

Nursing Care of a Patient with Prion Disease

Because of the complex nature and the lack of curative treatments, the nursing care of patients with prion diseases focuses on symptom management, supportive care, and ensuring the highest possible quality of life.

1.Symptom Management and Supportive Care

Pain Management

Patients with prion diseases may experience significant pain due to the progressive neurological damage. Effective pain management is crucial to improving their comfort and quality of life. Nurses should work closely with neurologists and pain specialists to administer appropriate pain relief medications, including analgesics and neuropathic pain agents. Regular assessment of pain levels and adjustment of treatment plans are essential.

Physical Therapy

Physical therapy plays a vital role in maintaining mobility and preventing complications such as muscle atrophy and contractures. Nurses should encourage and assist patients in performing regular exercises, tailored to their abilities. Collaboration with physical therapists can help develop individualized exercise programs that promote strength, flexibility, and overall physical well-being.

Psychological Support

The psychological impact of prion diseases on patients and their families can be profound. Nurses should provide compassionate emotional support, actively listening to patients’ concerns and fears. Referral to mental health professionals, such as psychologists or psychiatrists, may be necessary for more specialized care. Support groups for patients and families can also offer valuable peer support and coping strategies.

2.Comprehensive Care Approach

Multidisciplinary Collaboration

The care of patients with prion diseases requires a multidisciplinary approach involving neurologists, palliative care specialists, social workers, and other healthcare professionals. Nurses play a central role in coordinating care and ensuring seamless communication between team members. Regular case conferences and care plan updates help in addressing the evolving needs of patients.

Patient and Family Education

Educating patients and their families about prion diseases and their progression is essential. Nurses should provide clear and concise information about the nature of the disease, expected symptoms, and available supportive care options. Creating an open and supportive environment where questions and concerns are addressed can empower families to participate actively in the care process.

Infection Control

Given the infectious nature of prion diseases, strict infection control measures are paramount. Nurses must adhere to rigorous protocols for handling and disposing of contaminated materials. Personal protective equipment (PPE) should be used appropriately, and surfaces should be disinfected regularly to prevent the spread of infectious prions.

REFERENCES

1. Geschwind MD. Prion Diseases. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38. doi: 10.1212/CON.0000000000000251. PMID: 26633779; PMCID: PMC4879966.
2. Goldman JS, Vallabh SM. Genetic counseling for prion disease: Updates and best practices (https://pubmed.ncbi.nlm.nih.gov/35819418/). Genet Med. 2022 Oct;24(10):1993-2003.
3. Kishida H, Ueda N, Tanaka F. The advances in the early and accurate diagnosis of Creutzfeldt-Jakob disease and other prion diseases: where are we today? (https://pubmed.ncbi.nlm.nih.gov/37581576/) Expert Rev Neurother. 2023 Jul-Dec;23(9):803-817.
4. Merck Manual Consumer Version. Overview of Prion Diseases https://www.nih.gov/news-events/nih-research-matters/detecting-human-prion-disease. Updated 11/2022.
5. National Institute of Allergy and Infectious Diseases (U.S.). Therapeutic Approaches for Prion Diseases (https://www.niaid.nih.gov/diseases-conditions/prion-therapeutic-approaches). Updated 10/21/2019.
6. National Institute of Neurological Disorders and Stroke (U.S.). Transmissible Spongiform Encephalopathies (https://www.niaid.nih.gov/diseases-conditions/prion-therapeutic-approaches). Updated 1/23/2023.
7. National Institutes of Health (U.S.). Detecting Human Prion Disease https://www.nih.gov/news-events/nih-research-matters/detecting-human-prion-disease. Updated 12/29/2016.
8. Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases (https://pubmed.ncbi.nlm.nih.gov/30366560/). Neurol Clin. 2018 Nov;36(4):865-897.

Stories are the threads that bind us; through them, we understand each other, grow, and heal.

JOHN NOORD

Connect with “Nurses Lab Editorial Team”

I hope you found this information helpful. Do you have any questions or comments? Kindly write in comments section. Subscribe the Blog with your email so you can stay updated on upcoming events and the latest articles.